iHuman (IH) Stock Statistics & Valuation Metrics

iHuman has a market cap or net worth of $82.80M. The enterprise value is -$1.03B.

iHuman has 22,312,862 shares outstanding. The number of shares has decreased by -2.65% in one year.

iHuman’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 6.21%.

The current PE Ratio of iHuman is 1.6. iHuman’s PEG ratio is -0.50.

In the last 12 months, iHuman had revenue of 807.02M and earned 95.40M in profits. Earnings per share was 9.10.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

iHuman pays an annual dividend of $0.085, resulting in a dividend yield of 3.93%

iHuman upcoming earnings date is Jun 24, 2026, Before Open (Confirmed).

iHuman as a current ratio of 3.57, with Debt / Equity ratio of 1.14%

In the past 12 months, iHuman has paid 6.39M in taxes.

iHuman EV to EBITDA ratio is -13.28, with an EV/FCF ratio of -21.92.

iHuman has $1.10B in cash and marketable securities with $12.28M in debt, giving a net cash position of $1.09B billion.

Gross margin is 67.86%, with operating margin of 8.27%, and net profit margin of 11.82%.

The average price target for iHuman is ―, which is 11.43% higher than the current price. The consensus rating is ―